| # | Drug | Count |
|---|---|---|
| 0 | TACROLIMUS | 26 |
| 1 | CYTARABINE | 25 |
| 2 | TACROLIMUS EXTENDED-RELEASE CAPSULES | 24 |
| 3 | TACROLIMUS OINTMENT 0.1% | 24 |
| 4 | CYCLOPHOSPHAMIDE | 21 |
| 5 | CYCLOPHOSPHAMIDE FOR INJECTION | 21 |
| 6 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 21 |
| 7 | METHOTREXATE SODIUM | 20 |
| 8 | ETOPOSIDE | 18 |
| 9 | METHOTREXATE | 18 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | POTASSIUM DIHYDROGEN PHOSPHATE | 1 | 0.0345 |
| 1 | HEPATITIS B IMMUNE GLOBULIN (HUMAN) | 1 | 0.0196 |
| 2 | AMLODIPINE AND VALSARTAN | 2 | 0.0102 |
| 3 | ACETAMINOPHEN, CAFFEINE, PYRILAMINE MALEATE | 1 | 0.0067 |
| 4 | CASPOFUNGIN ACETATE | 3 | 0.0019 |
| 5 | PLERIXAFOR | 2 | 0.0013 |
| 6 | DEFEROXAMINE MESYLATE | 2 | 0.0009 |
| 7 | VANCOMYCIN HYDROCHLORIDE | 7 | 0.0008 |
| 8 | PYRIMETHAMINE | 1 | 0.0008 |
| 9 | TREOSULFAN | 2 | 0.0007 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 47 |
| 1 | Nucleoside Metabolic Inhibitor [EPC] | 30 |
| 2 | Azole Antifungal [EPC] | 25 |
| 3 | Alkylating Drug [EPC] | 22 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 20 |
| 5 | Folate Analog Metabolic Inhibitor [EPC] | 18 |
| 6 | Topoisomerase Inhibitor [EPC] | 18 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 15 |
| 8 | Penem Antibacterial [EPC] | 8 |
| 9 | Antimetabolite Immunosuppressant [EPC] | 7 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Human Immunoglobulin [EPC] | 1 | 0.0196 |
| 1 | Hematopoietic Stem Cell Mobilizer [EPC] | 2 | 0.0013 |
| 2 | Dihydrofolate Reductase Inhibitor Antimalarial [EPC] | 1 | 0.0008 |
| 3 | Echinocandin Antifungal [EPC] | 4 | 0.0005 |
| 4 | Lipid-based Polyene Antifungal [EPC] | 5 | 0.0004 |
| 5 | Antimetabolite Immunosuppressant [EPC] | 7 | 0.0003 |
| 6 | Sulfonamide Antibacterial [EPC] | 1 | 0.0003 |
| 7 | Topoisomerase Inhibitor [EPC] | 18 | 0.0002 |
| 8 | Penem Antibacterial [EPC] | 8 | 0.0002 |
| 9 | Asparagine-specific Enzyme [EPC] | 3 | 0.0002 |